Medpace Holdings, Inc. logo
Medpace Holdings, Inc. (MEDP)
Compare

MEDP Cash Flow Statement

Operating, investing, and financing cash flow analysis

MEDP Quarterly Cash Flow Statement (USD)

Quarterly ReportTTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
09/30/2024
06/30/2024
739.175M151.788M192.652M246.209M148.526M125.836M190.666M149.075M116.397M
460.398M123.870M135.133M111.135M90.260M114.595M117.018M96.426M88.351M
28.100M6.906M7.131M7.049M7.014M6.930M7.506M7.518M7.235M
22.812M4.918M5.620M6.323M5.951M16.892M5.889M11.727M3.588M
Change in Accounts Receivable
1.481B370.379M376.726M362.318M371.918M291.893M291.096M304.754M292.189M
Change in Inventory
Change in Accounts Payable
Change in Working Capital
106.472M-8.698M22.118M87.463M5.589M-18.892M78.806M29.007M11.185M
Cash from Investing
-1.356M-6.814M-4.536M16.107M-6.113M-9.994M-7.643M-10.537M-12.871M
0.000.000.000.000.000.000.000.000.00
Cash from Financing
Debt Repayment
-545.489M0.000.00-4.574M-540.915M-371.900M-169.867M0.000.00
0.000.000.000.000.000.000.000.000.00
737.819M144.974M188.116M262.316M142.413M115.842M183.023M138.538M103.526M
Net Change in Cash
211.245M155.632M211.698M239.021M-395.106M-228.000M12.536M146.006M103.884M

MEDP Annual Cash Flow Statement (USD)

Annual Report
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
713.223M608.815M433.374M388.050M263.327M258.676M201.867M156.584M
451.123M404.386M282.810M245.368M181.848M145.384M100.443M73.185M
28.124M29.251M26.328M22.341M21.119M19.528M23.189M38.801M
34.786M25.514M20.516M21.412M14.469M13.784M20.741M6.499M
Change in Accounts Receivable
376.726M291.096M275.925M212.999M150.325M137.912M155.662M133.449M
Change in Inventory
Change in Accounts Payable
Change in Working Capital
96.278M157.181M106.486M106.055M66.707M66.257M35.588M39.601M
Cash from Investing
-31.356M-36.548M-36.648M-36.879M-28.271M-31.340M-17.912M-16.024M
0.000.000.000.000.000.000.000.00
Cash from Financing
Debt Repayment
-917.389M-169.867M-144.020M-847.849M-62.096M-98.274M0.000.00
0.000.000.000.000.000.000.000.00
681.867M572.267M396.726M351.171M235.056M227.336M183.955M140.560M
Net Change in Cash
-172.387M423.987M217.184M-433.039M183.538M145.846M108.638M-3.210M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Medpace Holdings, Inc.

Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.

Cincinnati, OH
5,900 employees
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
August James Troendle